Completing data — refresh the page later to see the latest
403604-85-3COc1ccccc1Oc1c(NS(=O)(=O)/C=C/c2ccccc2)nc(-c2ncccn2)nc1OCLONWRQOYFPYMQD-DTQAZKPQSA-NNebentan is a small molecule drug. The usage of the INN stem '-entan' in the name indicates that Nebentan is a endothelin receptor antagonist. Nebentan has a monoisotopic molecular weight of 491.13 Da.
403604-85-3DTXSID50193350CHEMBL2107760UsesNebentan (YM598 free base) is a potent, selective and orally active non-peptide endothelin ETA receptor antagonist through the modification of Bosentan (HY-A0013). Nebentan inhibits [125I] endothelin-1 binding to cloned human endothelin ETA and ETB receptor, with Ki of 0.697 nM and 569 nM, respectively[1]. YM598 can ameliorate the progression of cor pulmonale and myocardial infarction in vivo[2].